1. Bartsch H，Nair U，Risch A，et al.Genetic polymorphism of CYP genes，alone or in combination，as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev，2000，9（1）：3-28.

2. Agundez JA.Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab，2004，5（3）：211-224.

3. Wang H，Tan W，Hao B，et al.Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13，the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res，2003，63（22）：8057-8061.

4. Xing D，Qi J，Miao X，et al.Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer，2002，100（5）：600-605.

5. Sakiyama T，Kohno T，Mimaki S，et al.Association of amino acid substitution polymorphisms in DNA repair genes TP53，POLI，REV1 and LIG4 with lung cancer risk. Int J Cancer，2005，114（5）：730-737.

6. Yang T，Lapinski PE，Zhao H，et al.A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing. Clin Cancer Res，2005，11（10）：3614-3623.

7. Sun T，Miao X，Zhang X，et al.Polymorphisms of death pathway genes FAS and FASL in esophageal squamouscell carcinoma. J Natl Cancer Inst，2004，96（13）：1030-1036.

8. Zhang X，Miao X，Sun T，et al.Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet，2005，42（6）：479-484.

9. Sun T，Gao Y，Tan W，et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet，2007，39（5）：605-613.

10. Klein RJ，Zeiss C，Chew EY，et al.Complement factor H polymorphism in age-related macular degeneration. Sci-ence，2005，308（5720）：385-389.

11. International HapMap C，Frazer KA，Ballinger DG，et al.A second generation human haplotype map of over 3.1 million SNPs. Nature，2007，449（7164）：851-861.

12. Steemers FJ，Gunderson KL.Whole genome genotyping technologies on the BeadArray platform. Biotechnologyjournal，2007，2（1）：41-49.

13. Kennedy GC，Matsuzaki H，Dong S，et al.Large-scale genotyping of complex DNA. Nature biotechnology，2003，21（10）：1233-1237.

14. Gunderson KL，Steemers FJ，Lee G，et al.A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet，2005，37（5）：549-554.

15. Purcell S，Neale B，Todd-Brown K，et al.a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics，2007，81（3）：559-575.

16. Price AL，Patterson NJ，Plenge RM，et al.Principal components analysis corrects for stratification in genomewide association studies. Nat Genet，2006，38（8）：904-909.

17. Studies N-NWGoRiA，Chanock SJ，Manolio T，et al.Replicating genotype-phenotype associations. Nature，2007，447（7145）：655-660.

18. Wang LD，Zhou FY，Li XM，et al.Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet，2010，42（9）：759-763.

19. Abnet CC，Freedman ND，Hu N，et al.A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet，2010，42（9）：764-767.

20. Wu C，Hu Z，He Z，et al.Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet，2011，43（7）：679-684.

21. Wu C，Kraft P，Zhai K，et al.Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet，2012，44（10）：1090-1097.

22. Chang J，Huang Y，Wei L，et al.Risk prediction of esophageal squamous-cell carcinoma with common genetic variants and lifestyle factors in Chinese population. Carcinogenesis，2013.

23. Wu C，Li D，Jia W，et al.Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat Genet，2013，45（6）：632-638.

24. Wu C，Miao X，Huang L，et al.Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet，2012，44（1）：62-66.

25. Hung RJ，McKay JD，Gaborieau V，et al.A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature，2008，452（7187）：633-637.

26. Amos CI，Wu X，Broderick P，et al.Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1. Nat Genet，2008，40（5）：616-622.

27. McKay JD，Hung RJ，Gaborieau V，et al.Lung cancer susceptibility locus at 5p15.33. Nat Genet，2008，40（12）：1404-1406.

28. Wang Y，Broderick P，Webb E，et al.Common 5p15.33 and 6p21.33 variants influence lung cancer risk. NatGenet，2008，40（12）：1407-1409.

29. Wu C，Hu Z，Yu D，et al.Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res，2009，69（12）：5065-5072.

30. Hu Z，Wu C，Shi Y，et al.A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet，2011，43（8）：792-796.

31. Dong J，Hu Z，Wu C，et al.Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet，2012，44（8）：895-899.

32. Dong J，Jin G，Wu C，et al.Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese. PLoS Genet，2013，9（1）：e1003190.

33. Lan Q，Hsiung CA，Matsuo K，et al.Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet，2012，44（12）：1330-1335.

34. Wu C，Xu B，Yuan P，et al.Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res，2010，70（23）：9721-9729.

35. Wu C，Xu B，Yuan P，et al.Genome-wide examination of genetic variants associated with response to platinumbased chemotherapy in patients with small-cell lung cancer. Pharmacogenet Genomics，2010，20（6）：389-395.

36. Hu L，Wu C，Zhao X，et al.Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res，2012，18（19）：5507-5514.

37. Beasley RP.Hepatitis B virus.The major etiology of hepatocellular carcinoma. Cancer，1988，61（10）：1942-1956.

38. Zhang H，Zhai Y，Hu Z，et al.Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet，2010，42（9）：755-758.

39. Li S，Qian J，Yang Y，et al.GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet，2012，8（7）：e1002791.

40. Jiang DK，Sun J，Cao G，et al.Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet，2013，45（1）：72-75.

41. Easton DF，Pooley KA，Dunning AM，et al.Genome-wide association study identifies novel breast cancer susceptibility loci. Nature，2007，447（7148）：1087-1093.

42. Hunter DJ，Kraft P，Jacobs KB，et al.A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet，2007，39（7）：870-874.

43. Gold B，Kirchhoff T，Stefanov S，et al.Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A，2008，105（11）：4340-4345.

44. Stacey SN，Manolescu A，Sulem P，et al.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet，2007，39（7）：865-869.

45. Stacey SN，Manolescu A，Sulem P，et al.Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet，2008，40（6）：703-706.

46. Zheng W，Long J，Gao YT，et al.Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet，2009，41（3）：324-328.

47. Long J，Cai Q，Shu XO，et al.Identification of a functional genetic variant at 16q12.1 for breast cancer risk：results from the Asia Breast Cancer Consortium. PLoS Genet，2010，6（6）：e1001002.

48. Cai Q，Long J，Lu W，et al.Genome-wide association study identifies breast cancer risk variant at 10q21.2：results from the Asia Breast Cancer Consortium. Hum Mol Genet，2011，20（24）：4991-4999.

49. Long J，Cai Q，Sung H，et al.Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet，2012，8（2）：e1002532.

50. Shu XO，Long J，Lu W，et al.Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res，2012，72（5）：1182-1189.

51. Bei JX，Li Y，Jia WH，et al.A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet，2010，42（7）：599-603.

52. Shi Y，Hu Z，Wu C，et al.A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet，2011，43（12）：1215-1218.

53. Xu J，Mo Z，Ye D，et al.Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13. 4. Nat Genet，2012，44（11）：1231-1235.

54. Jia WH，Zhang B，Matsuo K，et al.Genome-wide association analyses in east Asians identify new susceptibility loci for colorectal cancer. Nat Genet，2012，45（2）：191-196.

55. Tan DE，Foo JN，Bei JX，et al.Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet，2013，45（7）：804-807.

56. Thomson W，Barton A，Ke X，et al. Rheumatoid arthritis association at 6q23. Nat Genet，2007，39（12）：1431-1433.

57. Barton A，Thomson W，Ke X，et al.Rheumatoid arthritis susceptibility loci at chromosomes 10p15，12q13 and 22q13. Nat Genet，2008，40（10）：1156-1159.

58. Higgins JP，Little J，Ioannidis JP，et al.Turning the pump handle：evolving methods for integrating the evidence on gene-disease association. American journal of epidemiology，2007，166（8）：863-866.

59. de Bakker PI，Ferreira MA，Jia X，et al.Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet，2008，17（R2）：R122-128.

60. Zeggini E，Ioannidis JP.Meta-analysis in genome-wide association studies. Pharmacogenomics，2009，10（2）：191-201.

61. Zeggini E，Scott LJ，Saxena R，et al.Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet，2008，40（5）：638-645.

62. Higgins JP，Thompson SG，Deeks JJ.Measuring inconsistency in meta-analyses. Bmj，2003，327（7414）：557-560.

63. Ioannidis JP，Patsopoulos NA，Evangelou E.Heterogeneity in meta-analyses of genome-wide association investigations. PloS one，2007，2（9）：e841.

64. Cantor RM，Lange K，Sinsheimer JS.Prioritizing GWAS results：A review of statistical methods and recommendations for their application. American journal of human genetics，2010，86（1）：6-22.

65. Barrett JC，Hansoul S，Nicolae DL，et al.Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet，2008，40（8）：955-962.

66. Torkamani A，Topol EJ，Schork NJ.Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008，92（5）：265-272.

67. Perry JR，McCarthy MI，Hattersley AT，et al.Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes，2009，58（6）：1463-1467.

68. Freedman ML，Monteiro AN，Gayther SA，et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet，2011，43（6）：513-518.

69. Brest P，Lapaquette P，Souidi M，et al.A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet，2011，43（3）：242-245.

70. Chen R，Davydov EV，Sirota M，et al.Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PloS one，2010，5（10）：e13574.

71. Palstra RJ.Close encounters of the 3C kind：long-range chromatin interactions and transcriptional regulation. Briefings in functional genomics＆proteomics，2009，8（4）：297-309.

72. Pomerantz MM，Ahmadiyeh N，Jia L，et al.The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet，2009，41（8）：882-884.

73. Nejentsev S，Walker N，Riches D，et al.Rare variants of IFIH1，a gene implicated in antiviral responses，protect against type 1 diabetes. Science，2009，324（5925）：387-389.

74. Fellay J，Thompson AJ，Ge D，et al.ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature，2010，464（7287）：405-408.

75. Itsara A，Cooper GM，Baker C，et al.Population analysis of large copy number variants and hotspots of human genetic disease. American journal of human genetics，2009，84（2）：148-161.

76. McCarroll SA，Huett A，Kuballa P，et al.Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat Genet，2008，40（9）：1107-1112.

77. Nicolae DL，Gamazon E，Zhang W，et al.Trait-associated SNPs are more likely to be eQTLs：annotation to enhance discovery from GWAS. PLoS Genet，2010，6（4）：e1000888.

78. Rockman MV，Kruglyak L.Genetics of global gene expression. Nature reviews Genetics，2006，7（11）：862-872.

79. Cheung VG，Spielman RS.Genetics of human gene expression：mapping DNA variants that influence gene expression. Nature reviews Genetics，2009，10（9）：595-604.

80. Ding J，Gudjonsson JE，Liang L，et al.Gene expression in skin and lymphoblastoid cells：Refined statistical method reveals extensive overlap in cis-eQTL signals. American journal of human genetics，2010，87（6）：779-789.

81. Liang L，Morar N，Dixon AL，et al.A cross-platform analysis of 14，177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome research，2013，23（4）：716-726.

82. Bernstein BE，Meissner A，Lander ES.The mammalian epigenome， Cell，2007，128（4）：669-681.

83. Jones PA，Baylin SB.The epigenomics of cancer. Cell，2007，128（4）：683-692.

84. Hesson LB，Hitchins MP，Ward RL.Epimutations and cancer predisposition：importance and mechanisms. Currentopinion in genetics＆development，2010，20（3）：290-298.

85. Chan TL，Yuen ST，Kong CK，et al.Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet，2006，38（10）：1178-1183.

86. Kerkel K，Spadola A，Yuan E，et al.Genomic surveys by methylation-sensitive SNP analysis identify sequencedependent allele-specific DNA methylation. Nat Genet，2008，40（7）：904-908.

87. Zhang D，Cheng L，Badner JA，et al.Genetic control of individual differences in gene-specific methylation in human brain. American journal of human genetics，2010，86（3）：411-419.

88. Rakyan VK，Down TA，Balding DJ，et al.Epigenome-wide association studies for common human diseases. Naturereviews Genetics，2011，12（8）：529-541.